AVRA Medical Robotics, Inc. (OTC: AVMR )
was organized by a senior leadership team with broad and deep experience in medical research, innovation, and development in the medical robotics field. The company plans to exploit the growing demand for practical surgical robotic devices by developing a platform independent precision guidance system with an initial focus on skin resurfacing.
We believe that our Executive Management and Medical and Scientific Advisors have the demonstrated experience and professional skills to develop and market our robotic system successfully.
Our management team has had direct design, engineering and manufacturing experience in complex mechanical operations as well as the administration and supervision of the corporate activities of small and large enterprises ranging from pharma to telecommunications.
Our Medical Advisory Board consists of a number of surgeons who were active in the formative stages of robotic surgery in the United States and who today are numbered the most acknowledged and productive physicians in their specialties.
AVRA believes that its comprehensive and diverse team brings the necessary resources to develop and commercialize intelligent medical robotic systems, as well as in marketing, chain management, and the implementation of all other aspects of business operations.
Patient Inspired Technology
AVRA is a surgical digital technology company whose primary goal is to provide surgeons with the ability to achieve consistently excellent results for the patient. Employing advanced technology, AVRA is developing an intelligent robotic platform combining attributes of imaging with target acquisition and guidance to navigate with unprecedented accuracy and precision. These advanced, semi/autonomous systems will have boundless diagnostic and therapeutic applications — Target, Diagnose, Treat.
AVRA is currently developing a unique surgical robotic platform in the field of Aesthetics. According to the American Society for Aesthetic Plastic Surgery (ASAPS), the field of aesthetics is a $13.5 billion industry, with explosive growth in non-surgical treatments.